Gylynthia Trotman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gylynthia Trotman has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Veronica Gomez-Lobo
Paediatric and Adolescent Gynaecology Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development , Bethesda, MD
6 shared publications Helen Cheung
Georgetown University School of Medicine, Washington, District of Columbia
2 shared publicationsRenuka Darolia
Medstar Washington Hospital Center, Washington, District of Columbia
2 shared publications- Eleanor Race Mackey
Department of Psychiatry and Behavioral Sciences, Children’s National Hospital, Washington, United States
1 shared publication - Eshetu Tefera
Department of Biostatistics and Biomedical Informatics, MedStar Health Research Institute, Washington, DC. ORCID: https://orcid.org/
1 shared publication Lee Ann E. Conard
Division of Adolescent and Transition Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
1 shared publication
Latest Publications
- 1 July 2019
- Published by Taylor & Francis in International Journal of Transgenderism
- Vol. 20 (4) , 413-420
Hormonal contraceptive choices in a clinic-based series of transgender adolescents and young adults
Aims: To describe the use of hormonal contraceptives for menstrual management and/or pregnancy prevention in a clinic-based series of transgender adolescents and young adults who were assigned female at birth (transmasculine identity). Methods: We performed a chart review of post-menarchal transgender assigned-female-at-birth (AFAB) patients, age 10–25 years, seen at CCHMC Transgender Health Clinic for at least 2 visits between July 1, 2013 and September 17, 2016, and who were not on a puberty suppression method. We collected data including choice of hormonal contraceptive and indication (menstrual suppression, pregnancy prevention, or both), duration of use, initiation of sexual activity, reported sexual partners, and use of gender-affirming hormone therapy (i.e., testosterone). We present simple descriptive statistics. Results: A total of 231 patients met inclusion criteria, with ages from 11 to 25 years. Of those, 135 (59%) were using a hormonal contraceptive method. Most patients (67%) used hormonal contraception for the indication of menstrual suppression. Most commonly used method was depot medroxyprogesterone (DMPA) (49 patients), followed by combined oral contraceptives (COC) and norethindrone (progestin-only pill, POP) (34 patients each). Thirteen patients used 52 mg levonorgestrel IUD (LNG-IUD). Of the total sample (n = 231), 82 (36%) reported sexual activity, 35 of whom (43% of sexually active patients) reported sexual intercourse with assigned-male-at-birth (AMAB) partners and/or penile–vaginal intercourse. Among 35 patients at risk for pregnancy, only 21 (60%) were using hormonal contraception. Over half (54%) of sexually active patients taking testosterone discontinued their hormonal contraceptive method once they stopped having menses. Discussion: Within a sample of transgender AFAB adolescents, half of whom were taking testosterone, a variety of contraceptives were used, including depot medroxyprogesterone, combined oral contraceptives, and levonorgestrel IUD. Among those taking testosterone, many patients discontinued contraception once they stopped having menses.
- 1 July 2019
- Published by Taylor & Francis in International Journal of Transgenderism
- Vol. 20 (4) , 413-420
Hormonal contraceptive choices in a clinic-based series of transgender adolescents and young adults
Aims: To describe the use of hormonal contraceptives for menstrual management and/or pregnancy prevention in a clinic-based series of transgender adolescents and young adults who were assigned female at birth (transmasculine identity). Methods: We performed a chart review of post-menarchal transgender assigned-female-at-birth (AFAB) patients, age 10–25 years, seen at CCHMC Transgender Health Clinic for at least 2 visits between July 1, 2013 and September 17, 2016, and who were not on a puberty suppression method. We collected data including choice of hormonal contraceptive and indication (menstrual suppression, pregnancy prevention, or both), duration of use, initiation of sexual activity, reported sexual partners, and use of gender-affirming hormone therapy (i.e., testosterone). We present simple descriptive statistics. Results: A total of 231 patients met inclusion criteria, with ages from 11 to 25 years. Of those, 135 (59%) were using a hormonal contraceptive method. Most patients (67%) used hormonal contraception for the indication of menstrual suppression. Most commonly used method was depot medroxyprogesterone (DMPA) (49 patients), followed by combined oral contraceptives (COC) and norethindrone (progestin-only pill, POP) (34 patients each). Thirteen patients used 52 mg levonorgestrel IUD (LNG-IUD). Of the total sample (n = 231), 82 (36%) reported sexual activity, 35 of whom (43% of sexually active patients) reported sexual intercourse with assigned-male-at-birth (AMAB) partners and/or penile–vaginal intercourse. Among 35 patients at risk for pregnancy, only 21 (60%) were using hormonal contraception. Over half (54%) of sexually active patients taking testosterone discontinued their hormonal contraceptive method once they stopped having menses. Discussion: Within a sample of transgender AFAB adolescents, half of whom were taking testosterone, a variety of contraceptives were used, including depot medroxyprogesterone, combined oral contraceptives, and levonorgestrel IUD. Among those taking testosterone, many patients discontinued contraception once they stopped having menses.
- 1 April 2017
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 30 (2) , 234-238
Rate of Oophorectomy for Benign Indications in a Children's Hospital: Influence of a Gynecologist
- 1 April 2017
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 30 (2) , 234-238
Rate of Oophorectomy for Benign Indications in a Children's Hospital: Influence of a Gynecologist
- 1 February 2017
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 30 (1) , 144-145
Letter to the Editor
- 1 February 2017
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 30 (1) , 144-145
Letter to the Editor
- 1 April 2014
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 27 (2) , e59-e60
Endometriosis /Pelvic Pain Syndromes and Postural Tachycardia Syndrome: What is the Association and Treatment Implications?
- 1 April 2014
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 27 (2) , e59-e60
Endometriosis /Pelvic Pain Syndromes and Postural Tachycardia Syndrome: What is the Association and Treatment Implications?
- 1 April 2014
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 27 (2) , e38-e39
Ovarian Presevation at Time of Surgical Management for Benign Adnexal Pathology
- 1 April 2014
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 27 (2) , e38-e39
Ovarian Presevation at Time of Surgical Management for Benign Adnexal Pathology
- 1 April 2014
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 27 (2) , e37
Parent and Adolescent Attitudes Towards the Adolescent Confidential Interview in the Gynecologic Setting
- 1 April 2014
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 27 (2) , e37
Parent and Adolescent Attitudes Towards the Adolescent Confidential Interview in the Gynecologic Setting
- 1 April 2013
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 26 (2) , e68-e69
Antenatal Ovarian Torsion: Expectant Management or Early Surgical Intervention?
- 1 April 2013
- Published by Elsevier in Journal of Pediatric and Adolescent Gynecology
- Vol. 26 (2) , e68-e69
Antenatal Ovarian Torsion: Expectant Management or Early Surgical Intervention?